|
Volumn 6, Issue 2, 2008, Pages 122-174
|
Prevention and treatment of cancer-related infections
a a a a a a a a a a a a a a a a a a a
a
NONE
|
Author keywords
Absolute neutrophil count; Antibiotic resistant organisms; Antifungal agents; Antimicrobial; Antiviral agents; Cancer therapy; Fever; Guidelines; Infection; NCCN Clinical Practice Guidelines; Neutropenia; Stem cell transplant
|
Indexed keywords
ACICLOVIR;
ALEMTUZUMAB;
AMPHOTERICIN B;
COTRIMOXAZOLE;
FAMCICLOVIR;
FLUCONAZOLE;
METRONIDAZOLE;
OSELTAMIVIR;
POSACONAZOLE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
VALACICLOVIR;
VANCOMYCIN;
VORICONAZOLE;
ABDOMINAL PAIN;
BACTERIUM CULTURE;
BLOOD CULTURE;
CATHETER INFECTION;
CHICKENPOX;
CLOSTRIDIUM DIFFICILE;
CYTOMEGALOVIRUS INFECTION;
DIARRHEA;
FEVER;
FOLLOW UP;
GRAFT INFECTION;
HAND WASHING;
HERPES SIMPLEX;
HUMAN;
IMMUNOCOMPROMISED PATIENT;
INFECTION;
INFECTION CONTROL;
INFECTION PREVENTION;
INFECTION RISK;
INFLUENZA;
MUCOSA INFLAMMATION;
OPPORTUNISTIC INFECTION;
PATIENT ASSESSMENT;
PATIENT MONITORING;
PRACTICE GUIDELINE;
PYREXIA IDIOPATHICA;
REVIEW;
RISK ASSESSMENT;
TREATMENT PLANNING;
URINE CULTURE;
VASCULAR ACCESS;
VIRUS CULTURE;
|
EID: 40349096506
PISSN: 15401405
EISSN: 15401413
Source Type: Journal
DOI: 10.6004/jnccn.2008.0013 Document Type: Review |
Times cited : (115)
|
References (223)
|